Genocea Biosciences reported $20.14M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Agenus AGEN:US $ 228.38M 19.32M
Baxter International BAX:US $ 1852M 442M
Bluebird Bio BLUE:US $ 81.5M 24.76M
Cytokinetics CYTK:US $ 93.63M 21.79M
Cytori Therapeutics CYTX:US $ 18.09M 3.15M
Genocea Biosciences GNCA:US $ 20.14M 17.01M
Glaxosmithkline GSK:US $ 6465M 4502M
Infinity Pharmaceuticals INFI:US $ 45.84M 7.29M
Mirati Therapeutics MRTX:US $ 245.51M 47.91M
Moderna Inc MRNA:US 2.87B 2.18B
Novavax NVAX:US $ 1375.59M 195.37M
Prothena PRTA:US $ 508.8M 34.2M